Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 409 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · derivative · entry 9 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 819 Underlying: Bio-Rad A Common Stock · 409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,637 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,637 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 142 | $478.32 | $67,921.44 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 2 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589.2754 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 409 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 1 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731.2754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:20 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 241 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019286 · form4.xml · derivative · entry 3 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482 Underlying: Bio-Rad A Common Stock · 241 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:20 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Tax withholdingBio-Rad A Common Stock | 84 | $478.32 | $40,178.88 |
DisclosureSEC source: 0001062993-22-019286 · form4.xml · nonDerivative · entry 2 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365.4969 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:20 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionBio-Rad A Common Stock | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019286 · form4.xml · nonDerivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449.4969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:14 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 902 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019282 · form4.xml · derivative · entry 3 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,806 Underlying: Bio-Rad A Common Stock · 902 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:14 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 448 | $478.32 | $214,287.36 |
DisclosureSEC source: 0001062993-22-019282 · form4.xml · nonDerivative · entry 2 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,083.0091 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:14 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019282 · form4.xml · nonDerivative · entry 1 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,531.0091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · derivative · entry 9 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 125 | $478.32 | $59,790.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,598.2125 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723.2125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · derivative · entry 9 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 125 | $478.32 | $59,790.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 2 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,473.3347 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 1 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,598.3347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 9 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Bio-Rad A Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 150 | $478.32 | $71,748.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,620 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:04 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 541 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019274 · form4.xml · derivative · entry 3 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,084 Underlying: Bio-Rad A Common Stock · 541 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:04 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 269 | $478.32 | $128,668.08 |
DisclosureSEC source: 0001062993-22-019274 · form4.xml · nonDerivative · entry 2 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 953 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:04 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 541 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019274 · form4.xml · nonDerivative · entry 1 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:12 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 405 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019204 · form4.xml · derivative · entry 4 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,216 Underlying: Bio-Rad A Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:12 UTC |
WRIGHT DARAExecutive Vice President
|
GrantRestricted Stock Units · Derivative | 2,082 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019204 · form4.xml · derivative · entry 3 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,082 Underlying: Bio-Rad A Common Stock · 2,082 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:12 UTC |
WRIGHT DARAExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 141 | $486.25 | $68,561.25 |
DisclosureSEC source: 0001062993-22-019204 · form4.xml · nonDerivative · entry 2 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176.8996 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:12 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019204 · form4.xml · nonDerivative · entry 1 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317.8996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 20.8996 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:10 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 1,266 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019202 · form4.xml · derivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,798 Underlying: Bio-Rad A Common Stock · 1,266 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:10 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
GrantRestricted Stock Units · Derivative | 8,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019202 · form4.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,326 Underlying: Bio-Rad A Common Stock · 8,326 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:10 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 767 | $486.25 | $372,953.75 |
DisclosureSEC source: 0001062993-22-019202 · form4.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,169 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:10 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 1,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019202 · form4.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:07 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 30 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019200 · form4.xml · derivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92 Underlying: Bio-Rad A Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:07 UTC |
Allison SchwartzDirector
|
GrantRestricted Stock Units · Derivative | 167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019200 · form4.xml · derivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167 Underlying: Bio-Rad A Common Stock · 167 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:07 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 12 | $486.25 | $5,835.00 |
DisclosureSEC source: 0001062993-22-019200 · form4.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:07 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019200 · form4.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:00 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 169 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019198 · form4.xml · derivative · entry 4 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507 Underlying: Bio-Rad A Common Stock · 169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 676 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 676 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:00 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 694 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019198 · form4.xml · derivative · entry 3 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 Underlying: Bio-Rad A Common Stock · 694 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:00 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Tax withholdingBio-Rad A Common Stock | 59 | $486.25 | $28,688.75 |
DisclosureSEC source: 0001062993-22-019198 · form4.xml · nonDerivative · entry 2 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208.4969 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:00 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionBio-Rad A Common Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019198 · form4.xml · nonDerivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267.4969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:58 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 371 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019196 · form4.xml · derivative · entry 4 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Underlying: Bio-Rad A Common Stock · 371 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,486 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,486 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:58 UTC |
MAY SIMONEVP, President, LSG
|
GrantRestricted Stock Units · Derivative | 2,082 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019196 · form4.xml · derivative · entry 3 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,082 Underlying: Bio-Rad A Common Stock · 2,082 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:58 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 129 | $486.25 | $62,726.25 |
DisclosureSEC source: 0001062993-22-019196 · form4.xml · nonDerivative · entry 2 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322.2754 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:58 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 371 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019196 · form4.xml · nonDerivative · entry 1 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451.2754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 24.0465 and 12.8145 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2022 and 06/30/2022, respectively. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:56 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 633 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019194 · form4.xml · derivative · entry 4 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899 Underlying: Bio-Rad A Common Stock · 633 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:56 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 3,469 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019194 · form4.xml · derivative · entry 3 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,469 Underlying: Bio-Rad A Common Stock · 3,469 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:56 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 314 | $486.25 | $152,682.50 |
DisclosureSEC source: 0001062993-22-019194 · form4.xml · nonDerivative · entry 2 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629.0091 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:56 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 633 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019194 · form4.xml · nonDerivative · entry 1 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,943.0091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 16.8874 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019191 · form4.xml · derivative · entry 4 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760 Underlying: Bio-Rad A Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
GrantRestricted Stock Units · Derivative | 1,388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019191 · form4.xml · derivative · entry 3 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 Underlying: Bio-Rad A Common Stock · 1,388 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 88 | $486.25 | $42,790.00 |
DisclosureSEC source: 0001062993-22-019191 · form4.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,362.2125 Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:52 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019191 · form4.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450.2125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 13.9013, 1.0911, 13.6432, and 15.5238 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021, 12/31/2021, 03/31/2022 and 06/30/2022, respectively. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 17:50 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 329 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019189 · form4.xml · derivative · entry 4 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988 Underlying: Bio-Rad A Common Stock · 329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.